Healthcare -
Biotechnology - NASDAQ - US
$ 10.31
0.979 %
$ 1.1 B
Market Cap
-4.03
P/E
Price Target
Average
274.39%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
47.39%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Rocket Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for RCKT of $38.6 , with forecasts ranging from
a
low of
$32 to a high of $45 .
RCKT Lowest Price Target
Wall Street Target
32 USD
210.38%
RCKT Average Price Target
Wall Street Target
38.6 USD
274.39%
RCKT Highest Price Target
Wall Street Target
45 USD
336.47%
REVENUE FORECAST
Revenue Forecast Chart RCKT
EBIT FORECAST
EBIT Forecast Chart RCKT
NET INCOME FORECAST
Net Income Chart RCKT